Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia
Status:
Completed
Trial end date:
2023-04-05
Target enrollment:
Participant gender:
Summary
In the study that was conducted from 05.01.2009 - 31.12.2012. 120 patients were examined. By
drawing random numbers, the patients were randomized into 3 groups for postoperative
analgesia:
1. Diclofenac 2 mg/kg/day - control,
2. Wound infiltration via wound catheter with catheter tip placed in the axilla, 3*0.5
mg/kg 0.5% levobupivacaine bolus dose.
3. 0.05 mg/kg/h 0.5% levobupivacaine continuously via wound infiltration catheter with
catheter tip placed in the axilla. The drug was delivered using a PCA pump for 24 hours.
The aim was to compare early postoperative outcomes - pain control on a visual analog scale
of 1-10, hand grip strength, and quality of life after surgery and after 1 year.
Long-term survival was examined subsequently, from the hospital register.